Quest Diagnostics to offer Fujirebio Alzheimer's diagnostic test

3 hours ago 1

Quest Diagnostics (NYSE:DGX) announced plans to introduce a new laboratory test using the Lumipulse diagnostic technology from Fujirebio.
This test aims to help identify patients with amyloid pathology linked to Alzheimer's disease.
The company intends to provide this test to

Recommended For You